SE8200007L - Farmaceutisk komposition innehallande gamma-butyrobetain for behandling av l-karnitin-bristsyndrom - Google Patents

Farmaceutisk komposition innehallande gamma-butyrobetain for behandling av l-karnitin-bristsyndrom

Info

Publication number
SE8200007L
SE8200007L SE8200007A SE8200007A SE8200007L SE 8200007 L SE8200007 L SE 8200007L SE 8200007 A SE8200007 A SE 8200007A SE 8200007 A SE8200007 A SE 8200007A SE 8200007 L SE8200007 L SE 8200007L
Authority
SE
Sweden
Prior art keywords
carnitine
treatment
butyrobetain
lact
syndrome
Prior art date
Application number
SE8200007A
Other languages
Unknown language ( )
English (en)
Other versions
SE453569B (sv
Inventor
C Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SE8200007L publication Critical patent/SE8200007L/sv
Publication of SE453569B publication Critical patent/SE453569B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8200007A 1981-01-06 1982-01-04 Gammabutyrobetain till anvendning for behandling av patienter som lider av l-karnitinbristsyndrom SE453569B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (2)

Publication Number Publication Date
SE8200007L true SE8200007L (sv) 1982-07-07
SE453569B SE453569B (sv) 1988-02-15

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200007A SE453569B (sv) 1981-01-06 1982-01-04 Gammabutyrobetain till anvendning for behandling av patienter som lider av l-karnitinbristsyndrom

Country Status (15)

Country Link
US (1) US4382092A (sv)
JP (1) JPS57136516A (sv)
AU (1) AU548787B2 (sv)
BE (1) BE891639A (sv)
CH (1) CH649218A5 (sv)
DE (1) DE3200016A1 (sv)
FR (1) FR2497510B1 (sv)
GB (1) GB2091101B (sv)
GR (1) GR75132B (sv)
IE (1) IE52404B1 (sv)
IL (1) IL64632A0 (sv)
IT (1) IT1198434B (sv)
LU (1) LU83869A1 (sv)
NL (1) NL8200022A (sv)
SE (1) SE453569B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
DE3200016C2 (sv) 1992-12-03
JPH0424325B2 (sv) 1992-04-24
BE891639A (fr) 1982-04-16
SE453569B (sv) 1988-02-15
FR2497510B1 (fr) 1986-04-25
DE3200016A1 (de) 1982-08-12
AU7908781A (en) 1982-07-15
IE52404B1 (en) 1987-10-14
IE813099L (en) 1982-07-06
AU548787B2 (en) 1986-01-02
GB2091101B (en) 1985-02-20
NL8200022A (nl) 1982-08-02
IL64632A0 (en) 1982-03-31
IT8147518A0 (it) 1981-01-06
LU83869A1 (fr) 1982-05-07
GR75132B (sv) 1984-07-13
IT1198434B (it) 1988-12-21
CH649218A5 (it) 1985-05-15
US4382092A (en) 1983-05-03
JPS57136516A (en) 1982-08-23
GB2091101A (en) 1982-07-28
FR2497510A1 (fr) 1982-07-09

Similar Documents

Publication Publication Date Title
SE8200007L (sv) Farmaceutisk komposition innehallande gamma-butyrobetain for behandling av l-karnitin-bristsyndrom
DK460683D0 (da) Orale mopidamolformer og fremgangsmade til deres fremstilling
RU93055137A (ru) Гетероцикло-циклические производные аминов, способ получения, промежуточные соединения, фармацевтическая композиция, способ лечения
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
DK593886D0 (da) Forbindelser og farmaceutiske praeparater der inhiberer 5-lipoxygenase-vejen
SE7903817L (sv) Moranolinderivat
DK227083D0 (da) Farmaceutisk komposition og fremgangsmade til dens fremstilling
SE8803583L (sv) Farmaceutisk komposition
DK0585440T3 (da) 2-amino-1,2,3,4-tetrahydronaphtalen-derivater med virkning på det cardiovasculære system fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
NO166569C (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
IT1119854B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
SE8701077L (sv) Farmaceutisk beredning
FR2668150B1 (fr) Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
IT1157126B (it) N(vinblastin-23-il)derivati di aminoacidi loro preparazione ed applicazione terapeutica
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
IT1145371B (it) Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
DK314587A (da) 1,4-dihydropyridinderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
SU1024096A1 (ru) Способ лечени детей с хроническими неспецифическими заболевани ми легких
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
Evans Summer'86
IT1187666B (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari
UA15281A (uk) Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200007-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200007-6

Format of ref document f/p: F